Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
SABS compared with ANTX: revenue, margins and what each company keeps, and the suppliers and customers both name
SABS
SAB Biotherapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
ANTX
AN2 Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
SABS
SAB Biotherapeutics, Inc.
vs
ANTX
AN2 Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
SABS, solid
ANTX, dashed
SABS
SAB Biotherapeutics, Inc.
Change
3.02
▲
+2.59%
· post 3.02
Mkt cap
$273.0M
Revenue
$114,698
Q4 FY24
ANTX
AN2 Therapeutics, Inc.
Change
4.00
▲
+1.14%
· post 4.00
Closed
Nov 6 '26
Mkt cap
$150.9M
Revenue
—
vs
Compare
Closed
Nov 6 '26
SABS
SAB Biotherapeutics, Inc.
vs
ANTX
AN2 Therapeutics, Inc.
3.02
▲
+2.59%
post 3.02
Price
4.00
▲
+1.14%
post 4.00
$273.0M
Mkt cap
$150.9M
Q4 FY24
$114,698
Revenue
—
Change
Change
SABS
3.02
▲
+2.59%
vs
ANTX
4.00
▲
+1.14%
Closed
Nov 6 '26